| Literature DB >> 31164566 |
Abstract
Ionic liquids (ILs) have advanced a variety of applications, including matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS). ILs can be used as matrices and solvents for analyte extraction and separation prior to analysis using laser desorption/ionization-mass spectrometry (LDI-MS). Most ILs show high stability with negligible sublimation under vacuum, provide high ionization efficiency, can be used for qualitative and quantitative analyses with and without internal standards, show high reproducibility, form homogenous spots during sampling, and offer high solvation efficiency for a wide range of analytes. Ionic liquids can be used as solvents and pseudo-stationary phases for extraction and separation of a wide range of analytes, including proteins, peptides, lipids, carbohydrates, pathogenic bacteria, and small molecules. This review article summarizes the recent advances of ILs applications using MALDI-MS. The applications of ILs as matrices, solvents, and pseudo-stationary phases, are also reviewed.Entities:
Keywords: extraction; ionic liquid matrices; ionic liquids; matrix-assisted laser desorption/ionization–mass spectrometry; separation
Year: 2018 PMID: 31164566 PMCID: PMC6526421 DOI: 10.3390/mps1020023
Source DB: PubMed Journal: Methods Protoc ISSN: 2409-9279
Chemical compositions and applications of ionic liquids (ILs) for matrix-assisted laser desorption/ionization–mass spectrometry (MALDI–MS) as matrices.
| Acid | Base | Analyte | Conditions | Low Limit of Detection (LOD, pmol) | Linear Range (pmol) | Ref. |
|---|---|---|---|---|---|---|
| CHCA | 1-methylimidazole, aniline, pyridine, | ODNs, proteins 5′-d(CTTTCCTC) and 5′-d(TCTTCCCTT), bradykinin, Tyr-bradykinin, substance P, melittin, and bovine insulin |
Voyager DE-RP mass spectrometer Nitrogen laser (337 nm, 3 ns pulse) Linear positive-ion mode The acceleration voltage was 20 kV Grid voltage was 95%, Guide-wire voltage was 0.1% Delay time was 200 ns | 2 μM to 50 μM | [ | |
| 3-aminoquinoline | Tetrapeptide RFDS, bradykinin fragment 1-7, angiotensin I, substance P, Glu-fibrinopeptide, ANP 104-123, ACTH 18-39, Somatostatin, and ACTH 7-38 |
Waters Micromass Q-TOF Premier Spot size of about 200–300 μm | 1 | 0.001–2 | [ | |
| Phosphatidylcholine (PC) in mouse brain tissue |
Lasertechnik Berlin Nitrogen laser (337 nm, a pulse energy of 1.5 µJ) | 30 | 1–100 | [ | ||
| Bradykinin, substance-P, melittin, allatostatin IV |
MALDI FTMS spectra were collected with a 3 tesla FTMS Nitrogen laser (337 nm) Full power (60–70 μJ). The laser spot size is 0.196 mm2 | 5000 | [ | |||
| Triethylamine, diisopropylammine | Drugs |
Micromass MALDI-LR® Nitrogen laser (337 nm) A pulse voltage of 2.5 kV; a delay extraction of 500 ns; an accelerating voltage of 15 kV Reflectron voltage of 2 kV | [ | |||
| 2-aminopentane (AP) | N-acyl homoserine lactones (AHL) |
AB SCIEX MALDI TOF/TOF 5800 mass spectrometer Nd:YAG laser (355 nm) A pulse rate of 400 Hz Accumulating 2000 shots | 0.125–5 | [ | ||
| 1-methylimidazole, aniline, pyridine, tripropylamine, tributylamine | Phosphatidylcholine (PC), phosphatidic acid (PA), phophatidylethanolamine (PE), serine (PS), glycerol (PG), and inositol (PI) |
A Voyager DE-STR mass spectrometer Nitrogen laser (337 nm) Acceleration of 20 kV, Delay time of 400 ns 200 laser shots | 127 × 103 | [ | ||
| Polymers and additives found in lubricant residues |
Bruker Daltonics AutoFlex Nitrogen laser (337 nm) | 0.5% and 0.003% lubricant in biological fluid | [ | |||
| 3-aminoquinoline, | Peptides Y5R, Y6, and substance P arginine, imipramine, and serotonin |
MNL100 Lasertechnik Nitrogen laser (337 nm) | 10−2 | 10−2–103 | [ | |
| Bradykinin, polyethylene glycol 4600, insulin, cytochrome |
Bruker Autoflex and Bruker Flex Analysis Software Nitrogen laser (337 nm) | 50–100 | [ | |||
| 3-aminoquinoline (3-AQ) | Glycan |
AXIMA-Resonance UV-MALDI Nitrogen laser (337 nm) 3 ns pulse width The maximum laser pulse rate is 10 Hz | 1 × 10−3 | [ | ||
| 1-methylimidazolium | Glycosaminoglycan (GAG) polysaccharides |
4800 MALDI TOF/TOF™ Analyzer Nitrogen laser (337 nm) Reflectron negative mode Accelerating voltage 1 kV | [ | |||
| CHCA | Triethylamine | Aflatoxins B1, B2, G1, and G2 |
Micromass Nitrogen laser (337 nm) Reflectron and positive ion modes Pulse voltage, 2450 V Delay extraction 100 ns Acelerating voltage, 15 kV Reflectron voltage, 2 kV | 0.05 | [ | |
| 2,5-dihydroxybenzoic acid (DHB), CHCA, Sinapic acid | Butylamine, Triethylamine | Glycoconjugates, peptides, and proteins oligosaccharides, polymers desialylation of sialylactose, sialidase from |
A Voyager DE-STR MALDI-TOF MS Nitrogen laser (337 nm) Acceleration voltage, 20–25 kV Grid voltage, 95% and 72% Guidewire voltage, 0.05% Extraction delay time, 300–550 ns | 0.3–2.5 | [ | |
| CHCA and ferulic acid | Mannan, β-Cyclodextran |
Bruker Autoflex mass spectrometer | 103 | [ | ||
| DHB | Aniline, | Sialylated Glycans |
Bruker Biflex IV MALDI-TOF Nitrogen laser (337 nm) Positive-ion extraction mode Accelerating voltage 9.3–20 kV | 30 | [ | |
| Maltohexaose, maltoheptaose, |
Bruker UltrafleXtreme™ mass spectrometer Nd:YAG laser (355 nm) Positive and reflectron mode Accelerating potential 20 kV | 0.01 | 10–80 | [ | ||
|
Bruker Biflex IV Nitrogen laser (337 nm) Positive ion reflecting mode | 7–22.4 | 0.7–22.4 | [ | |||
| Butylamine | Pullulans |
AXIMA-LNR Nitrogen laser (337 nm) Accelerating voltage of 20 kV 200 laser shots | 0.8–4.4 | [ | ||
| Oligosaccharides |
SolariX 7.0 Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) Nd:YAG laser (355 nm) | 38 | 340–555 | [ | ||
| CHCA | 1,1,3,3-tetramethylguanidium (TMG) | Sulfated/sialylated/neutral oligosaccharides |
AXIMA-QIT Nitrogen laser (337 nm) 100 laser shots for each analysis | 0.001 | [ | |
| CHCA and DHB | 1-methylimidazolium | Sucrose octasulfate, and an octasulfatedpentasaccharide, Arixtra |
TofSpec2E MALDI-TOF Nitrogen laser (337 nm) Reflectronand positive mode Accelerating voltage 20–26 kV | 8–40 | [ | |
| Mefenamic acid | Aniline (ANI), Pyridine (Pyr), Dimethyl aniline (DMANI), 2-methyl picoline (2-P)) | Drugs, carbohydrate, and amino acids. |
Bruker Microflex IV Nitrogen laser (337 nm) | 1–20 | [ | |
| 1,1,3,3-tetramethylguanidium (TMG) | Anion adducted |
µFocus MALDI plate TM 700 µm Nitrogen laser (337 nm) 100 laser shots | 0.001 for NO3–, 0.001 for BF4– | [ | ||
| THAP | Phosphopeptides |
Autoflex speed TOF/TOF mass spectrometer Nd:YAG laser (355 nm) Laser energy 5–10% above the ionization threshold 500 laser shots The delayed extraction time 150 ns | [ | |||
| ATT | DMAN |
Waters MicroMX MALDI Nitrogen laser (337 nm) Tubevoltage12 kV Reflectronvoltage5.2 kV Anode voltage 5 kV accelerate voltage 20 kV, MCP detector Voltage19.5 kV Extraction delay 500 ns | 5 × 10−4 | 0–100 | [ | |
| HABA | 1,1,3,3-tetramethylguanidine | Polysulfated carbohydrates such as heparin (HP) and heparan sulfate (HS) |
Biosystems Voyager-DE Pro STR MALDI-TOF Nitrogen laser (337 nm) Pulsed at a 20 Hz frequency Negative ion reflector mode Accelerating potential of −20 kV | 67 | [ | |
| DHB | Tributylamine (TBA), Pyridine (Py), 1-methylimidazole(MI) | Arabinose, biotin, thiamine, NAD, ascorbic acid, a-ketoglutarate, ATP |
Bruker Reflex III Nitrogen laser (337 nm) Energy of 400 mJ/pulse Accelerated voltage 20 kV | 0.01 | 0.25–2.5 | [ |
Notes: ATP: Adenosine 5-triphosphate; ATT: 6-aza-2-thiothymine; CHCA: α-Cyano-4-hydroxycinnamic acid; DMAN: 1,8-bis(dimethyl-amino)naphthalene; HABA: 2-(4-hydroxyphenylazo)benzoic acid; NAD: nicotinamide adenine dinucleotide; ODNs: oligodeoxynucleotides; SA: Sinapinic acid; THAP; 2,4,6-trihydroxyacetophenone.
Extraction and separation using ionic iquids prior to analysis for matrix assisted laser desorption/ionization mass spectrometry.
| ILs | Extraction/Separation Technique | Analytes | Instrumental Parameters | LOD | Conditions | Ref. |
|---|---|---|---|---|---|---|
| CHCAB | DLLME | Phospholipids from soybean |
Bruker Daltonics, Nitrogen laser (337 nm) Positive ion mode Acceleration voltage 20 kV Pulse voltage 1300 V Extraction delay time 225 ns 400 laser shots | 5 and 18 fmol (LOQ) | 5 min extraction time in the presence of 30 mg/mL CHCAB and 1.2% NaCl, using chloroform as an extracting solvent and methanol as a dispersing solvent | [ |
| 1-alkyl-3-methylimidazolium PF6 (Cnmim, | LLME | Uranyl nitrate |
Bruker Protein-TOF™ Nitrogen laser (337 nm) Pulse width of 3 ns 400 laser shots Both positive and negative modes | 0.014–0.098 M | 0.1–0.5 M using NaNO3 in 1.0 M HNO3, TBP (tributyl phosphate) concentration of 1.0 M in the RTILS or in dodecane | [ |
| 3-methylimidazolium bis[(trifluoromethyl)sulfonyl]amide and 1-butyl-3-methylimidazolium bis[(trifluoromethyl)sulfonyl]amide, 1-hexyl-3-methylimidazolium bis[(trifluoromethyl)sulfonyl] amide and 1-octyl-3-methylimidazolium bis[(trifluoromethyl)sulfonyl]amide | Sr2+ and Cs+ |
Voyager DE MALDI–TOF | 1.5 mM | 1 mL of IL, extracted with 10 mL of cation-containing aqueous solution (1.5 mM) for 60 min in a vibrating mixer. | [ | |
| PR4+ cations and ferulate (FA), CHCA, and DHB anions | single-step extraction | Dyes from textiles, malachite green, nile blue nile red, bromothymol blue, fluorescein, kiton red |
4800 Plus MALDI–TOF/TOF 200 Hz Nd:YAG laser (355 nm) 400 shots per | 0–98% | Samples were centrifuged at 2000 rpm for 30 min, pH 7.5–10, 50–90 °C | [ |
| Tetrabutylphosponium chloride IL [Bu4P][Cl] | Single-Pot Extraction | dyes associated with structurally robust wool fibers |
4800 PlusMALDI–TOF/TOF 200 Hz ND:YAG(355 nm) | 0.005 mg of dye per mg of dyed wool into the IL | A cloudy red solution was produced after 24 h. The solution was filtered through a 0.45 µM syringe filter and spotted on the MALDI–MS plate in 1 µL aliquots, either neat or diluted 10,000-fold in methanol | [ |
| Platinum nanoparticles mixed 1-butyl-3-methylimidazolium hexafluorophosphate | SDME |
Microflex MALDI-MS Nitrogen laser (337 nm) Accelerating voltage of 20 kV 150 laser shots | 106cfu mL−1 | A glass vial was filled with 1 mL of sample solution, spiked with the bacteria; the sample solution was agitated on a magnetic stirrer at room temperature,a 2.0 mL portion of platinum nanoparticles prepared in IL was drawn into a 10 mL microsyringe | [ | |
| 3-Aminoquinoline/CHCA (3AQ/CHCA) | On-target separation | peptides and oligosaccharides |
AXIMA-QIT™ Nitrogen laser 337 nm wavelength | 5 pmol | Vaporization of water derived from analyte solvent | [ |
| Cationic ionic liquid-modified Fe3O4@SiO2 magnetic nanoparticles (CILMS) | Magnetic field |
Bruker Microflex Nitrogen laser 337 nm wavelength | 3.4 × 103, 3.2 × 103, and 4.2 × 103 cfu mL−1 | <5 min, RT, and use of external magnetic field | [ | |
| Triethylamine/CHCA | TLC | three arborescidine alkaloids, the anesthesics levobupivacaine and mepivacaine, and the antibiotic tetracycline |
Micromass MALDI-TOF Pulse voltage, 2450 V Delay extraction, 100 ns Accelerating voltage, 15 kV Reflectron voltage, 2 kV | 5–10 ng | Elution with CHCl3/MeOH 9:1 | [ |
| 1-butyl-3methylimidazolium hexafluorophosphate | on-target separation |
Microflex, Bruker Nitrogen laser (337 nm) Accelerating voltages +20 kV Laser energy of 63.2 μJ 200 laser shots | 107–109cfu/mL | 10 μL of yogurt was added to 100 μL of IL (containing 0.35 mg of AgNPs) and incubated for 10 min before spotting on the MALDI plate. | [ |
Notes: DLLME: dispersive liquid-liquid microextraction; LLME: liquid-liquid microextraction; SPE: Single-pot extraction-analysis; TLC: Thin-layer chromatography; LOQ: limits of quantification.
Figure 1Proton transfer between conventional organic matrices (left) or ionic liquids matrices (right) and an analyte for matrix assisted laser desorption/ionization mass spectrometry.
Figure 2(A) Plot of normalized [M + Na]+ ion intensities of the oligosaccharide maltoheptaose with 2,5-DHB butylamine (DHBB) (black squares) and DHB matrix (grey circles). (B) Resulting [M + H]+ ion intensities from a human angiotensin II preparation with α-cyno-4-hydroxycinnamic acid-butylamine (CHCAB) (black triangles) and CHCA matrices (grey squares). Figure reprinted with permission from Reference [86].
Figure 3Extraction procedure of dyes using tetraalkylphosphonium (PR4+)-based ionic liquids. Figure reprinted with permission from reference [156].
Figure 4Single-drop microextraction (SDME) using ILs for the extraction of pathogenic bacteria from aqueous suspensions. Figure reprinted with permission from reference [158].
Figure 5Schematic illustrations of the preparation of cationic IL-modified magnetic nanoparticles (CILMS) and the capture of bacteria by the magnetic nanoparticles. Reproduced from reference [160] with permission from The Royal Society of Chemistry. TEOS: Tetraethoxysilane; TEM: Transmission electron microscope.